PubRank

J Rak

Author PubWeight™ 74.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest 2000 5.52
2 Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 1997 2.82
3 Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis. Cancer Res 2001 2.78
4 CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997 2.71
5 Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. Cancer Metastasis Rev 2001 2.16
6 Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 1999 1.93
7 New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Ann Rheum Dis 2008 1.31
8 Establishing a link between oncogenes and tumor angiogenesis. Mol Med 1998 1.29
9 Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J Cell Biol 2000 1.27
10 Downregulation of the pro-apoptotic protein Bak is required for the ras-induced transformation of intestinal epithelial cells. Curr Biol 1998 1.20
11 von Hippel-Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids. Cancer Res 1998 1.20
12 Origin of chemiluminescence accompanying the reaction of the 9-cyano-10-methylacridinium cation with hydrogen peroxide. J Org Chem 2004 1.18
13 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Eur J Cancer 2000 1.18
14 Measurement of direct photon production in p+p collisions at sqrt[s] = 200 GeV. Phys Rev Lett 2007 1.16
15 Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 2000 1.12
16 Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett 2010 1.12
17 Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett 2012 1.11
18 Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int J Cancer 1999 1.10
19 Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett 2013 1.08
20 The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 1995 1.06
21 Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76  TeV. Phys Rev Lett 2011 1.05
22 Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors. Hum Cell 1996 1.02
23 Elevated tissue factor procoagulant activity in CD133-positive cancer cells. J Thromb Haemost 2007 0.99
24 The hemostatic system and angiogenesis in malignancy. Neoplasia 2001 0.99
25 Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76  TeV. Phys Rev Lett 2012 0.98
26 bFGF and tumor angiogenesis--back in the limelight? Nat Med 1997 0.98
27 Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma. Oncogene 1999 0.98
28 RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. Cancer Res 2001 0.97
29 Multicellular resistance: a new paradigm to explain aspects of acquired drug resistance of solid tumors. Cold Spring Harb Symp Quant Biol 1994 0.97
30 Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett 2011 0.93
31 Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. Oral Oncol 1999 0.90
32 Absence of suppression in particle production at large transverse momentum in sqrt[s(NN)]=200 GeV d+Au collisions. Phys Rev Lett 2003 0.87
33 Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experiment. Phys Rev Lett 2010 0.87
34 The dormant in vivo phenotype of early stage primary human melanoma: termination by overexpression of vascular endothelial growth factor. Angiogenesis 1998 0.86
35 Transition in yield and azimuthal shape modification in dihadron correlations in relativistic heavy ion collisions. Phys Rev Lett 2010 0.85
36 HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Clin Exp Rheumatol 2008 0.84
37 Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype. Cancer Res 1996 0.84
38 Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas. Gastroenterology 2001 0.83
39 J/ψ elliptic flow in Pb-Pb collisions at √(s(NN))=2.76 TeV. Phys Rev Lett 2013 0.82
40 Suppressed pi(0) production at large transverse momentum in central Au+Au collisions at sqrt[s(NN)]=200 GeV. Phys Rev Lett 2003 0.81
41 Pseudorapidity density of charged particles in p+Pb collisions at √(s(NN))=5.02 TeV. Phys Rev Lett 2013 0.81
42 Measurement of direct photons in Au+Au collisions at √(s(NN))=200 GeV. Phys Rev Lett 2012 0.81
43 Quadrupole anisotropy in dihadron azimuthal correlations in central d+Au collisions at √(s(NN))=200 GeV. Phys Rev Lett 2013 0.80
44 Charge separation relative to the reaction plane in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett 2013 0.80
45 Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk. J Thromb Haemost 2014 0.80
46 Pion, kaon, and proton production in central Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett 2012 0.80
47 J/ψ polarization in pp collisions at √s=7 TeV. Phys Rev Lett 2012 0.80
48 Laryngeal cancer in Lower Silesia: descriptive analysis of 501 cases. Oral Oncol 1998 0.80
49 System size and energy dependence of jet-induced hadron pair correlation shapes in Cu+Cu and Au+Au collisions at square root sNN=200 and 62.4 GeV. Phys Rev Lett 2007 0.79
50 Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers. Arch Immunol Ther Exp (Warsz) 1986 0.79
51 Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype. J Thromb Haemost 2013 0.79
52 A disconnect between antitumor and antiangiogenic effects of fluvastatin in vitro and in vivo. Neoplasma 2006 0.79
53 Medium modification of jet fragmentation in Au+Au collisions at √[s(NN)]=200 GeV measured in direct photon-hadron correlations. Phys Rev Lett 2013 0.78
54 Quasidegeneracy of zwitterionic and canonical tautomers of arginine solvated by an excess electron. J Am Chem Soc 2001 0.78
55 Arteriogenic expansion of extratumoral macrovessels - impact of vascular ageing. Neoplasma 2015 0.77
56 Suppression pattern of neutral pions at high transverse momentum in Au + Au collisions at sqrt[sNN]=200 GeV and constraints on medium transport coefficients. Phys Rev Lett 2008 0.77
57 Functional dissociation of anoikis-like cell death and activity of stress activated protein kinase. Biochem Biophys Res Commun 1999 0.77
58 Cytologic appearance of esthesioneuroblastoma in a fine needle aspirate. Acta Cytol 1988 0.76
59 Measurement of high-pT single electrons from heavy-flavor decays in p + p collisions at square root of s = 200 GeV. Phys Rev Lett 2006 0.76
60 The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model. J Thromb Haemost 2003 0.76
61 Nuclear modification of electron spectra and implications for heavy quark energy loss in Au+Au collisions at [FORMULA: SEE TEXT]. Phys Rev Lett 2006 0.76
62 Cross section and parity-violating spin asymmetries of W± boson production in polarized p + p collisions at sqrt[s] = 500 GeV. Phys Rev Lett 2011 0.76
63 Centrality dependence of charm production from a measurement of single electrons in Au+Au collisions at sqrt[s(NN)]=200 GeV. Phys Rev Lett 2005 0.76
64 Nuclear modification of ψ', χc, and J/ψ production in d+Au collisions at sqrt[s(NN)]=200  GeV. Phys Rev Lett 2013 0.75
65 Novel mutants define genes required for the expression of human histocompatibility leukocyte antigen DM: evidence for loci on human chromosome 6p. J Exp Med 1997 0.75
66 Measurement of bottom versus charm as a function of transverse momentum with electron-hadron correlations in p + p collisions at square root of s = 200 GeV. Phys Rev Lett 2009 0.75
67 Scaling properties of proton and antiproton production in sqrt[s(NN)]=200 GeV Au+Au collisions. Phys Rev Lett 2003 0.75
68 Cold nuclear matter effects on J/ψ yields as a function of rapidity and nuclear geometry in d+A collisions at sqrt[s(NN)]=200  GeV. Phys Rev Lett 2011 0.75
69 J/ψ suppression at forward rapidity in Pb-Pb collisions at √s(NN) = 2.76 TeV. Phys Rev Lett 2012 0.75
70 Charged-particle multiplicity density at midrapidity in central Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett 2010 0.75
71 Enhanced production of direct photons in Au + Au collisions at square root(S(NN)) = 200 GeV and implications for the initial temperature. Phys Rev Lett 2010 0.75
72 Measurement of identified and inclusive photon second-harmonic parameter and implications for direct photon production in [FORMULA: SEE TEXT] Au+Au. Phys Rev Lett 2006 0.75
73 The preparation and characterization of poly(D,L-lactic acid) for use as a biodegradable drug carrier. Pharm Acta Helv 1985 0.75
74 Influence of auxiliary substances on the release of heptacaine from the drug form. Acta Pharm Hung 1996 0.75
75 [Progress in pharmaceutical technology during 1970 and 1971]. Cesk Farm 1972 0.75
76 Enhanced production of low-mass electron-positron pairs in 40-AGeV Pb-Au collisions at the CERN SPS. Phys Rev Lett 2003 0.75
77 The ultrastructure of the kidney glomeruli in a selected group of childrens glomerulonephritis. Acta Med Pol 1979 0.75
78 Saturation of azimuthal anisotropy in Au + Au collisions at (square root)s(NN) = 62-200 GeV. Phys Rev Lett 2005 0.75
79 Universal pion freeze-out in heavy-ion collisions. Phys Rev Lett 2003 0.75
80 Gluon-spin contribution to the proton spin from the double-helicity asymmetry in inclusive pi0 production in polarized p+p collisions at [sqrt]s=200 GeV. Phys Rev Lett 2009 0.75
81 Measurement of the cross section for electromagnetic dissociation with neutron emission in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett 2012 0.75
82 Common suppression pattern of eta and pi0 mesons at high transverse momentum in Au + Au collisions at square root S(NN) = 200 GeV. Phys Rev Lett 2006 0.75
83 [Conceptual questions in the health service information system]. Cesk Zdrav 1984 0.75
84 Evolution of π(0) suppression in Au+Au collisions from √(s(NN))=39 to 200 GeV. Phys Rev Lett 2012 0.75
85 Dense-medium modifications to jet-induced hadron pair distributions in Au+Au collisions at sqrt s NN=200 GeV. Phys Rev Lett 2006 0.75
86 Particle-species dependent modification of jet-induced correlations in Au+Au collisions at sqrt[s_{NN}]=200 GeV. Phys Rev Lett 2008 0.75
87 Heparin compromises streptokinase-induced arterial patency in rabbits. Thromb Res 2005 0.75
88 Suppression of high-p{T} neutral pion production in central Pb+Pb collisions at sqrt[S{NN}]=17.3 GeV relative to p+C and p+Pb collisions. Phys Rev Lett 2008 0.75
89 Onset of pi(0) suppression studied in Cu+Cu collisions at sqrt S NN=22.4, 62.4, and 200 GeV. Phys Rev Lett 2008 0.75
90 Nuclear modification factors for hadrons at forward and backward rapidities in deuteron-gold collisions at sqrt[s(NN)]=200 GeV. Phys Rev Lett 2005 0.75
91 Azimuthal angle correlations for rapidity separated Hadron pairs in d+Au collisions at square root of sNN=200 GeV. Phys Rev Lett 2006 0.75
92 [Histological and histochemical investigation of pathological laryngeal mucosa with papillomatosis in children and adults]. Otolaryngol Pol 1998 0.75
93 [The role of sclerotherapy in the treatment of esophageal varices in children]. Otolaryngol Pol 1992 0.75
94 Interferometry of direct photons in central 208Pb + 208Pb collisions at 158A GeV. Phys Rev Lett 2004 0.75
95 [Progress in drug technology in 1974 and 1975]. Cesk Farm 1976 0.75
96 Semihard scattering unraveled from collective dynamics by two-pion azimuthal correlations in 158A GeV/c Pb+Au collisions. Phys Rev Lett 2004 0.75
97 Bose-Einstein correlations of charged pion pairs in Au + Au collisions at square root sNN = 200 GeV. Phys Rev Lett 2004 0.75
98 [Rheologic properties of Vivastar P 5000 hydrogel]. Ceska Slov Farm 2003 0.75
99 J/psi production from proton-proton collisions at square root of s=200 GeV. Phys Rev Lett 2004 0.75
100 Azimuthal anisotropy of π⁰ production in Au+Au collisions at sqrt((s)NN)=200  GeV: path-length dependence of jet quenching and the role of initial geometry. Phys Rev Lett 2010 0.75
101 Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer. Acta Otorhinolaryngol Belg 1998 0.75
102 [Studies on tablets. XIII. Determination of the scope of permanent deformation induced by changes in the apparent density of tablets]. Cesk Farm 1976 0.75
103 Suppression of back-to-back hadron pairs at forward rapidity in d+Au collisions at √s(NN)=200 GeV. Phys Rev Lett 2011 0.75
104 Three-pion interferometry results from central Pb+Pb collisions at 158A GeV/c. Phys Rev Lett 2000 0.75
105 Leptonic and charged kaon decay modes of the phi meson measured in heavy-ion collisions at the CERN super proton synchrotron. Phys Rev Lett 2006 0.75
106 J/psi production and nuclear effects for d + Au and p + p collisions at square root of S(NN) = 200 GeV. Phys Rev Lett 2006 0.75
107 Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates. J Immunopharmacol 1986 0.75
108 Midrapidity neutral-pion production in proton-proton collisions at square root s = 200 GeV. Phys Rev Lett 2003 0.75
109 [Progress in the manufacturing and control of tablets. XV. Mathematical interpretation of the pressure process]. Cesk Farm 1975 0.75
110 Elliptic and hexadecapole flow of charged hadrons in Au+Au collisions at sq.rt(s(NN))=200  GeV. Phys Rev Lett 2010 0.75
111 [Studies of tablets. XIX. Properties of tablets from basic granulate prepared by granulation from liquid phase]. Cesk Farm 1968 0.75
112 Metal-based particles in human amniotic fluids of fetuses with normal karyotype and congenital malformation--a pilot study. Environ Sci Pollut Res Int 2015 0.75
113 [Lower Silesia register of laryngeal neoplasms (1981-1985)]. Otolaryngol Pol 1988 0.75
114 Elliptic flow of identified hadrons in Au+Au collisions at sqrt sNN =200 GeV. Phys Rev Lett 2003 0.75
115 [Familial occurrence of congenital defects of the external ear]. Otolaryngol Pol 1987 0.75
116 Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. II. Reduction of the cyclophosphamide effect by repopulation with cells from lymphoid organs. Arch Immunol Ther Exp (Warsz) 1985 0.75
117 Observation of direct-photon collective flow in Au + Au collisions at √s(NN)] = 200 GeV. Phys Rev Lett 2012 0.75
118 [Study on tablets. XXII. Hardness of granulates, hardness of tablets and their mutual relationship]. Cesk Farm 1976 0.75
119 [Stability of acetylsalicylic acid in dosage forms]. Cesk Farm 1971 0.75
120 [Study on tablets. XVIII. Preparation of basic granulates for tablets by pulverization]. Cesk Farm 1968 0.75
121 Emerging anticoagulants: mechanism of action and future potential. Vnitr Lek 2006 0.75
122 [Studies on tablets. XXIV. Influence of the speed of compression and of various other factors in the condensation of powdered materials]. Cesk Farm 1976 0.75
123 Source breakup dynamics in Au + Au collisions at sqrt[s(NN)]=200 GeV via three-dimensional two-pion source imaging. Phys Rev Lett 2008 0.75
124 Lectin-resistant variants of mouse Lewis lung carcinoma cells. I. Selection and in vivo properties. Clin Exp Metastasis 1990 0.75
125 [Drug forms for drug delivery into the gastrointestinal tract]. Ceska Slov Farm 1995 0.75
126 Scaling properties of azimuthal anisotropy in Au+Au and Cu+Cu Collisions at sqrt[s NN]=200 GeV. Phys Rev Lett 2007 0.75
127 Expression of L-PHA binding oligosaccharides and progression of mammary neoplasia are unrelated. Int J Cancer 1993 0.75
128 Erratum: Evolution of π^{0} Suppression in Au+Au Collisions from sqrt[s_{NN}]=39 to 200 GeV [Phys. Rev. Lett. 109, 152301 (2012)]. Phys Rev Lett 2020 0.75
129 [Acute suppurative otitis media in leukemia]. Otolaryngol Pol 1985 0.75
130 Obituary. J Extracell Vesicles 2014 0.75
131 Potentiation of cyclophosphamide-induced enhancement of experimental metastasis by splenectomy. Arch Immunol Ther Exp (Warsz) 1989 0.75
132 [Worldwide aspects of teaching the subject, "dosage forms"]. Cesk Farm 1980 0.75
133 [Advances in pharmaceutical technology in 1966-1967. II. Drugs and pharmaceutical preparations]. Cesk Farm 1968 0.75
134 J/psi production in sqrt s_NN=200 GeV Cu+Cu collisions. Phys Rev Lett 2008 0.75
135 A study of local anaesthetics. Part 148. Influence of auxiliary substances on the surface tension, distribution coefficient and pharmaceutical availability from solutions of the potential drug VII. Acta Pol Pharm 1999 0.75
136 Charged Kaon interferometric probes of space-time evolution in Au+Au collisions at sqrt[S(NN)]=200 GeV. Phys Rev Lett 2009 0.75
137 [Etiology of laryngeal neoplasms--results of epidemiologic tests in Upper and Lower Silesia]. Otolaryngol Pol 1992 0.75
138 [Study on tablets. XXVII. Study on the deformative tension in the compression of aminophenazone tablets]. Cesk Farm 1977 0.75
139 [Case of a primary abdominal form of Hodgkin's disease]. Pol Tyg Lek 1982 0.75
140 [Histological and electron microscopic examinations of laryngeal papilloma in children and adults]. Otolaryngol Pol 1990 0.75
141 [Problems of standardizing the density of antigens for the Leptospira microagglutination test]. Cesk Epidemiol Mikrobiol Imunol 1983 0.75
142 [The problem of diagnosing tumors of the nose and paranasal sinuses]. Otolaryngol Pol 1989 0.75
143 [Advances in pharmaceutical technology in years 1966-1967. I. General works, pharmaceutic aids, manufacturing processes, packing technic]. Cesk Farm 1968 0.75
144 J/psi production versus transverse momentum and rapidity in p+p collisions at square root s=200 GeV. Phys Rev Lett 2007 0.75
145 [Drugs as one of the principle pharmaceutical categories]. Cesk Farm 1988 0.75
146 Evidence for a long-range component in the pion emission source in Au+Au collisions at sqrt sNN=200 GeV. Phys Rev Lett 2007 0.75
147 [Liberation of potential local anesthetics from colloidal dispersions]. Ceska Slov Farm 2002 0.75
148 Influence of hydrogel bases on liberation rate and structural viscosity of potential drug XX Z. Acta Pol Pharm 2000 0.75
149 Measurement of nonrandom event-by-event fluctuations of average transverse momentum in square root of (sNN)=200 GeV Au+Au and p+p collisions. Phys Rev Lett 2004 0.75
150 Differentiation of pathogenic and saprophytic leptospira strains. Zentralbl Bakteriol Mikrobiol Hyg A 1984 0.75
151 Irreversible electron attachment - a key to DNA damage by solvated electrons in aqueous solution. Org Biomol Chem 2015 0.75
152 [Control investigations of changes of certain oxidoreductive enzymes in nasal mucosa in surgically treated patients with ozena (author's transl)]. Otolaryngol Pol 1980 0.75
153 Centrality dependence of direct photon production in (square root)S(NN) = 200 GeV Au + Au collisions. Phys Rev Lett 2005 0.75
154 Antitumor effect of selected daunorubicin derivatives in mice with P 388 leukemia. Arch Immunol Ther Exp (Warsz) 1986 0.75
155 [Advances in pharmaceutical technology in the years 1972 and 1973]. Cesk Farm 1974 0.75
156 [Theory and practice within the framework of pharmaceutical education]. Ceska Slov Farm 1995 0.75
157 [Electron microscopic studies of various cases of glomerulonephritis (preliminary report)]. Patol Pol 1979 0.75
158 Single electrons from heavy-flavor decays in collisions at. Phys Rev Lett 2006 0.75
159 J/psi production versus centrality, transverse momentum, and rapidity in Au+Au collisions at square root sNN=200 GeV. Phys Rev Lett 2007 0.75
160 Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect. Arch Immunol Ther Exp (Warsz) 1985 0.75
161 Measurements of higher order flow harmonics in Au+Au collisions at √s(NN)=200 GeV. Phys Rev Lett 2011 0.75
162 [Quality assurance in nursing. When does quality assurance make sense?]. Pflege Z 1997 0.75
163 Elliptic flow for phi mesons and (anti)deuterons in Au+Au collisions at square root of sNN=200 GeV. Phys Rev Lett 2007 0.75
164 [Program in the manufacturing and control of tablets. XIII. Transfer of forces and distribution of tension during the pressing process]. Cesk Farm 1975 0.75
165 [Investigations of the ototoxicity of dicortinef (ear drops)]. Otolaryngol Pol 1992 0.75
166 [Problem of nephelometric assessment of Leptospira concentrations in cultures (author's transl)]. Cesk Epidemiol Mikrobiol Imunol 1981 0.75
167 [Localization of T, spiralis larvae in several types of muscle fibers of skeletal muscles in laboratory mice]. Wiad Parazytol 1978 0.75
168 Measurement of transverse single-spin asymmetries for midrapidity production of neutral pions and charged hadrons in polarized p + p collisions at square root(s) = 200 GeV. Phys Rev Lett 2005 0.75
169 Double helicity asymmetry in inclusive midrapidity pi0 production for polarized p+p collisions at square root s = 200 GeV. Phys Rev Lett 2004 0.75
170 Deuteron and antideuteron production in Au+Au collisions at square root of s(NN)=200 GeV. Phys Rev Lett 2005 0.75
171 [Progress in pharmaceutical technology during 1978]. Cesk Farm 1980 0.75
172 Cold-nuclear-matter effects on heavy-quark production in d+Au collisions at sqrt[S(NN)]=200 GeV. Phys Rev Lett 2012 0.75
173 The influence of glycerol, propylene glycol and sorbitol on surface tension, partition coefficient and diffusion of pyrrolidinoethylester of 3-heptyloxy phenylcarbamic acid (drug XX Z). Acta Pol Pharm 1997 0.75